B
B

Barclays

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

NatWest lifts staff pay after cost of living backlash

By Iain Withers LONDON, Dec 1 (Reuters) - NatWest NWG.L has offered the bulk of its 41,500 staff in Britain a pay rise and one-off cash sum to help them cope with soaring prices, after a backlash from some employees who missed out on a pay boost for lower-paid workers earlier this year. Companies across Britain are grappling with how much to increase salaries by as the end of the year nears and when inflation is at a 41-year high of 11.1%.
B
H
L

Barclays fined $10 mln over lack of card fees transparency

LONDON, Dec 1 (Reuters) - Britain's Payment Systems Regulator (PSR) has fined Britain's Barclays BARC.L bank 8.4 million pounds ($10.2 million) for failing to give retailers full information about card costs, the watchdog said on Thursday. Over three years from December 2015 retailers were unable to easily understand the transaction fees associated with accepting certain types of card payments, making it harder to compare prices in search of better deals, the PSR said.
B

Barclays fined $10 mln over lack of card fees transparency

LONDON, Dec 1 (Reuters) - Britain's Payment Systems Regulator (PSR) has fined Britain's Barclays BARC.L bank 8.4 million pounds ($10.2 million) for failing to give retailers full information about card costs, the watchdog said on Thursday. "It's vital that retailers and consumers get value for money on payment services – the interchange fee rules are an important part of making sure this happens," PSR Managing Director Chris Hemsley said in a statement.
B

Bank of England consults on remaining Basel bank capital rules

LONDON, Nov 30 (Reuters) - The Bank of England confirmed on Wednesday that the rollout of remaining global bank capital rules would start in January 2025, with smaller lenders not required to apply them. Known as Basel III, the rules were agreed globally after taxpayers had to bail out undercapitalised lenders in the global financial crisis over a decade ago.
B
H
L

Barclays CEO says doctors 'very optimistic' as cancer detected early

By Lawrence White and Iain Withers LONDON, Nov 29 (Reuters) - Barclays Chief Executive C.S. Venkatakrishnan said on Tuesday that his cancer was detected early and is "very localised", meaning that doctors are very optimistic about treating it. The British bank said on Monday that Venkatakrishnan would undergo treatment in New York for non-Hodgkin lymphoma.
B
J

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.